TG Therapeutics Investigational Trial Site

Amherst, New York 14266

1 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing Multiple Sclerosis, Relapsing Multiple Sclerosis (RMS)

Studies at this site

• A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS) — Recruiting now
• An Extension Study of Ublituximab in Participants With Relapsing Multiple Sclerosis — Running, not enrolling